Coronary atherosclerosis and thrombosis
1Center for Thrombosis and Vascular Research, University of Leuven, Belgium.
Insights
Atherosclerosis involves complex plaque development and rupture, leading to thrombosis. This dynamic process, including mural thrombus formation and embolization, drives the episodic progression of cardiovascular disease and clinical events.
Area of Science:
- Cardiovascular Science
- Pathology
- Thrombosis Research
Background:
- Atherosclerosis is a complex arterial disease characterized by plaque buildup.
- Plaque composition (fibrous tissue, calcium, lipids, inflammatory cells) determines its consistency and stability.
- Soft plaques with lipid cores and thin fibrous caps are prone to rupture.
Purpose of the Study:
- To elucidate the intricate relationship between atherosclerotic plaque characteristics and thrombus formation.
- To explain how plaque instability and rupture precipitate thrombotic events.
- To describe the dynamic, episodic nature of atherosclerotic disease progression and its clinical manifestations.
Main Methods:
- Review of existing literature on atherosclerosis and thrombosis.
- Analysis of plaque morphology and composition.
- Correlation of pathological findings with clinical outcomes.
Main Results:
- Plaque rupture or fissure allows luminal blood entry, causing dissection and fibrin deposition.
- Plaque instability and rupture are key triggers for arterial and mural thrombosis.
- Thrombus formation, fragmentation, and embolization contribute to intermittent occlusions and acute ischemic events.
- The dynamic interplay between atherosclerotic progression and thrombosis dictates the episodic clinical course.
Conclusions:
- The relationship between atherosclerosis and thrombosis is multifaceted, extending beyond simple arterial occlusion.
- Plaque rupture is a critical event initiating thrombosis and driving cardiovascular disease progression.
- Understanding these dynamics is crucial for managing ischemic heart disease and preventing sudden cardiac death.
Abstract:
The relationship of thrombus to atherosclerosis is complex and far more wide-reaching than the obvious causal association of a thrombotic occlusion in a coronary artery with myocardial infarction. An atherosclerotic plaque may be eccentric (localized primarily along one segment of the arterial wall) or concentric (localized circumferentially) and is a complex structure composed of connective tissue, calcium, inflammatory cells and lipid in proportions differing from plaque to plaque. The consistency of plaques depends on the proportion of their component elements: a heavily fibrotic and calcified plaque is hard, whereas a plaque composed predominantly of cholesterol-ester and lipid-containing macrophages is soft. Plaques with a soft lipid core may be covered by a relatively thin cap of fibrous connective tissue separating the plaque material from the luminal blood flow. A rupture or fissure of this cap allows blood to enter the plaque causing dissection of its structure and deposition of fibrin in the plaque. Fissuring commonly promotes thrombosis also in the lumen of the artery and may be followed by thrombus fragmentation and embolization. Mural thrombi may wax and wane, causing intermittent occlusions and fleeting, minor clinical symptoms. Further episodes of thrombosis increase the mass of the mural thrombus in the already restricted lumen and may herald the onset of ischemic symptoms, abruptly aggravate a stable clinical state and produce the crescendo type of unstable angina, dysrhythmias, myocardial infarction or sudden coronary death. The episodic dynamic progress of atherosclerotic disease and local thrombosis governs the episodic evolution of the clinical course.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg&w=3840&q=50)

